Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT Analysis Review

Date: June 14, 2016
Pages: 39
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: U6ED5648795EN
Leaflet:

Download PDF Leaflet

Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT Analysis Review
Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Universal Biosensors, Inc. (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBI’s major focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. Its in vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS) in Melbourne. UBI is headquartered in Melbourne, Victoria, Australia.

Universal Biosensors, Inc. Key Recent Developments

Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director
Jul 23, 2015: Half Yearly Report and SEC Form 10Q for Q2 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Universal Biosensors, Inc. - Key Facts
Universal Biosensors, Inc. - Key Employees
Universal Biosensors, Inc. - Key Employee Biographies
Universal Biosensors, Inc. - Major Products and Services
Universal Biosensors, Inc. - Medical Equipment Pipeline Products Data
Universal Biosensors, Inc. Pipeline Products by Equipment Type
Universal Biosensors, Inc. Pipeline Products by Development Stage
Universal Biosensors, Inc. - History
Universal Biosensors, Inc. - Company Statement
Universal Biosensors, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Universal Biosensors, Inc. - Business Description
Universal Biosensors, Inc. - Corporate Strategy
Universal Biosensors, Inc. - SWOT Analysis
SWOT Analysis - Overview
Universal Biosensors, Inc. - Strengths
Strength - Research and Development Activities
Strength - Novel Strip and Meter Technologies
Strength - Strategic Alliances and Partnerships
Universal Biosensors, Inc. - Weaknesses
Weakness - Operating Loss Carryforward
Weakness - Declining Cash Reserves
Universal Biosensors, Inc. - Opportunities
Opportunity - Growing Point-of-Care Testing Market
Opportunity - Growing Diabetes Care Devices Market
Opportunity - Growth in Emerging Economies
Universal Biosensors, Inc. - Threats
Threat - Single Manufacturing Facility
Threat - Risk of Product Obsolescence
Threat - Stiff Competition
Universal Biosensors, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Universal Biosensors, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Universal Biosensors, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Universal Biosensors, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director
Jul 23, 2015: Half Yearly Report and SEC Form 10Q for Q2 2015

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Universal Biosensors, Inc., Key Facts
Universal Biosensors, Inc., Key Employees
Universal Biosensors, Inc., Key Employee Biographies
Universal Biosensors, Inc., Major Products and Services
Universal Biosensors, Inc. Number of Pipeline Products by Equipment Type
Universal Biosensors, Inc. Pipeline Products by Equipment Type
Universal Biosensors, Inc. Number of Pipeline Products by Development Stage
Universal Biosensors, Inc. Pipeline Products by Development Stage
Universal Biosensors, Inc., History
Universal Biosensors, Inc., Subsidiaries
Universal Biosensors, Inc., Key Competitors
Universal Biosensors, Inc., Ratios based on current share price
Universal Biosensors, Inc., Annual Ratios
Universal Biosensors, Inc., Interim Ratios
Universal Biosensors, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Universal Biosensors, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Universal Biosensors, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Universal Biosensors, Inc. Pipeline Products by Equipment Type
Universal Biosensors, Inc. Pipeline Products by Development Stage
Universal Biosensors, Inc., Performance Chart (2011 - 2015)
Universal Biosensors, Inc., Ratio Charts
Universal Biosensors, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Universal Biosensors, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Siemens Healthcare GmbH
Roche Diagnostics International Ltd.
Diagnostica Stago SAS
Beckman Coulter, Inc.
Bayer Corporation
Alere Inc.
Abbott Point of Care Inc.
Skip to top


Ask Your Question

Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: